Medimaps

Medimaps has developed advanced imaging software that measures bone mineral density with a special type of X-ray device, called DXA. Medimaps’ software helps to better diagnose osteoporosis, a health condition that weakens bones and makes them more likely to break. Medimaps has already convinced more than 2’500 clinical centers as customers. The software has gained international recognition with more than 720 peer-reviewed publications and is part of official country osteoporosis guidelines.
medimaps logo colour- Verve Ventures portfolio
Founders / Management Prof. Didier Hans
Sectors Health & Bio, MedTech
Located in Geneva, Switzerland
Co-Investors Swisscanto Invest
Follow On

LinkedIn

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.